MedElevator
Войти в исследования Neuroradiology · 2025
Endovascular treatment of small-parent artery aneurysms: mid-term results of the silk vista baby flow diverter.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cinar Celal, Elek Alperen, Kusbeci Mahmut, Ozturk Egemen, Utli Cemre Yanbol, Oran Ismail
Аннотация
PURPOSE: We aim to retrospectively evaluate patients treated with SVB at our single center, assessing its efficacy, radiologic and clinical outcomes, and complication profile.
METHOD: This retrospective, single-center study included patients with small parent artery aneurysms treated with SVB. Patients were monitored for procedural success, aneurysm occlusion, and complications, with radiologic and clinical follow-up conducted.
RESULTS: The study included 64 patients with 66 small parent artery aneurysms treated using SVB FDs. Among these patients, 26 (40.6%) presented with subarachnoid hemorrhage (SAH). The mean index aneurysm size was 5.7 ± 5.25 mm. The cohort consisted of 15 males (23.4%) and 49 females (76.6%), with a mean age of 54.23 ± 14.95 years (range: 5-80 years). SVB was used as a standalone treatment in 42 patients (65.6%), while adjunctive materials were applied in 22 cases (34.4%)-coils in 16 (24.2%) and a regular stent in 6 (9.1%). A total of 71 SVB stents were deployed for 66 aneurysms, achieving a 100% technical success rate. In 30 patients with multiple aneurysms, additional aneurysms were addressed during the same session along with the index aneurysm. The mean duration of clinical and radiological follow-up was 10.5 ± 7.94 months. Among a total of 7 patients (10.9%) with ischemic complications, 3 (4.7%) were related to SVB implantation. Index aneurysm occlusion was accomplished in 93.3% of cases at the last follow-up. Favorable neurological outcomes (mRS 0-2) were recorded in 53 patients (82.8%). Subgroup analysis showed that 6 out of 7 total complications (85.7%) occurred in patients with multiple aneurysms.
CONCLUSION: The SVB FDs are a highly effective and safe treatment option for distal intracranial aneurysms, achieving high occlusion rates with a favorable safety profile.
METHOD: This retrospective, single-center study included patients with small parent artery aneurysms treated with SVB. Patients were monitored for procedural success, aneurysm occlusion, and complications, with radiologic and clinical follow-up conducted.
RESULTS: The study included 64 patients with 66 small parent artery aneurysms treated using SVB FDs. Among these patients, 26 (40.6%) presented with subarachnoid hemorrhage (SAH). The mean index aneurysm size was 5.7 ± 5.25 mm. The cohort consisted of 15 males (23.4%) and 49 females (76.6%), with a mean age of 54.23 ± 14.95 years (range: 5-80 years). SVB was used as a standalone treatment in 42 patients (65.6%), while adjunctive materials were applied in 22 cases (34.4%)-coils in 16 (24.2%) and a regular stent in 6 (9.1%). A total of 71 SVB stents were deployed for 66 aneurysms, achieving a 100% technical success rate. In 30 patients with multiple aneurysms, additional aneurysms were addressed during the same session along with the index aneurysm. The mean duration of clinical and radiological follow-up was 10.5 ± 7.94 months. Among a total of 7 patients (10.9%) with ischemic complications, 3 (4.7%) were related to SVB implantation. Index aneurysm occlusion was accomplished in 93.3% of cases at the last follow-up. Favorable neurological outcomes (mRS 0-2) were recorded in 53 patients (82.8%). Subgroup analysis showed that 6 out of 7 total complications (85.7%) occurred in patients with multiple aneurysms.
CONCLUSION: The SVB FDs are a highly effective and safe treatment option for distal intracranial aneurysms, achieving high occlusion rates with a favorable safety profile.